Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NeuroVive Pharmaceutical AB Year End Report January - December 2019 2020-02-19 16:08
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study 2019-12-23 08:33
NeuroVive Announces Settlement in Dispute With CicloMulsion AG 2019-12-16 18:33
NeuroVive Pharmaceutical AB Interim Report January - September 2019 2019-11-20 16:38
NeuroVive Pharmaceutical AB Interim Report January - June 2019 2019-08-21 15:24
NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation 2019-07-28 21:47
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study 2019-07-04 21:05
NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA 2019-05-10 15:05
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report 2019-03-25 17:58
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study 2019-03-19 15:58
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders 2018-11-15 19:37
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval 2018-10-10 14:49
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI 2018-10-04 15:43
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan 2018-09-06 15:10
NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia 2018-08-28 15:21
NeuroVive Pharmaceutical AB Interim Report January - June 2018 2018-08-21 15:22
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics 2018-06-19 04:39
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2018-05-31 20:09
NeuroVive Pharmaceutical AB Interim Report January - March 2018 2018-05-22 15:22
NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development 2018-05-21 17:26
1 2 3 4